![β2-agonists do not work in children under 2 years of age: myth or maxim? | European Respiratory Society β2-agonists do not work in children under 2 years of age: myth or maxim? | European Respiratory Society](https://breathe.ersjournals.com/content/breathe/15/4/273/F1.large.jpg)
β2-agonists do not work in children under 2 years of age: myth or maxim? | European Respiratory Society
![Fixed-dose combination of inhaled corticosteroid and long-acting beta 2... | Download Scientific Diagram Fixed-dose combination of inhaled corticosteroid and long-acting beta 2... | Download Scientific Diagram](https://www.researchgate.net/publication/291517568/figure/tbl1/AS:787744762642436@1564824395441/Fixed-dose-combination-of-inhaled-corticosteroid-and-long-acting-beta-2-agonist-in-the.png)
Fixed-dose combination of inhaled corticosteroid and long-acting beta 2... | Download Scientific Diagram
![Anabolic and lipolytic actions of beta2‐agonists in humans and antidoping challenges - Hostrup - 2020 - Drug Testing and Analysis - Wiley Online Library Anabolic and lipolytic actions of beta2‐agonists in humans and antidoping challenges - Hostrup - 2020 - Drug Testing and Analysis - Wiley Online Library](https://analyticalsciencejournals.onlinelibrary.wiley.com/cms/asset/28bdc4a8-32bf-4c5c-ac34-c19770c1cb5e/dta2728-fig-0001-m.jpg)
Anabolic and lipolytic actions of beta2‐agonists in humans and antidoping challenges - Hostrup - 2020 - Drug Testing and Analysis - Wiley Online Library
![PDF] Do long-acting beta2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD? | Semantic Scholar PDF] Do long-acting beta2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92b46301ce2fb548ac907cbd29bbb88363b804a4/2-Figure2-1.png)
PDF] Do long-acting beta2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD? | Semantic Scholar
![Table 2 from Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. | Semantic Scholar Table 2 from Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2efa96cf6b57178b8ed6a0ce30e70c7c1bfcc2b6/96-Table2-1.png)
Table 2 from Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. | Semantic Scholar
![Table 1 from Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. | Semantic Scholar Table 1 from Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c6b8d0ee7b688da71e94900d540176f65e3c1d22/54-Table1-1.png)